Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma

Published:2014-11-19 Issue:6 Volume:56 Page:1742-1749
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Fiskvik Idun,Beiske Klaus,Delabie Jan,Yri Olav,Spetalen Signe,Karjalainen-Lindsberg Marja-Liisa,Leppä Sirpa,Liestøl Knut,Smeland Erlend B,Holte Harald

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.970550

Reference48 articles.

1. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

2. A decade of R-CHOP

3. Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era

4. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

5. Stromal Gene Signatures in Large-B-Cell Lymphomas

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure elucidation, immunomodulatory activity, antitumor activity and its molecular mechanism of a novel polysaccharide from Boletus reticulatus Schaeff;Food Science and Human Wellness;2023-03

2. Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma;eJHaem;2022-06-23

3. Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma;Scientific Reports;2021-03-18

4. The prognostic importance of double-expressor subgroup and AID , UNG and mismatch repair protein expressions in diffuse large B-cell lymphomas;Marmara Medical Journal;2020-05-31

5. Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis;Blood Advances;2020-05-07